KR830004856A - 안정화된 안과 조성물의 제조방법 - Google Patents
안정화된 안과 조성물의 제조방법 Download PDFInfo
- Publication number
- KR830004856A KR830004856A KR1019810000921A KR810000921A KR830004856A KR 830004856 A KR830004856 A KR 830004856A KR 1019810000921 A KR1019810000921 A KR 1019810000921A KR 810000921 A KR810000921 A KR 810000921A KR 830004856 A KR830004856 A KR 830004856A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- process according
- ophthalmic composition
- preparing
- mercurythiosalicylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims 9
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 238000000034 method Methods 0.000 claims 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- HXQVQGWHFRNKMS-UHFFFAOYSA-M ethylmercurithiosalicylic acid Chemical compound CC[Hg]SC1=CC=CC=C1C(O)=O HXQVQGWHFRNKMS-UHFFFAOYSA-M 0.000 claims 2
- 239000007951 isotonicity adjuster Substances 0.000 claims 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims 2
- 229910052753 mercury Inorganic materials 0.000 claims 2
- 230000003204 osmotic effect Effects 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 230000002335 preservative effect Effects 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims 2
- 229960001082 trimethoprim Drugs 0.000 claims 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 108010040201 Polymyxins Proteins 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical group OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000008121 dextrose Substances 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 229940054534 ophthalmic solution Drugs 0.000 claims 1
- 239000002997 ophthalmic solution Substances 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8009589 | 1980-03-21 | ||
| GB8009589 | 1980-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR830004856A true KR830004856A (ko) | 1983-07-20 |
Family
ID=10512277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019810000921A Ceased KR830004856A (ko) | 1980-03-21 | 1981-03-20 | 안정화된 안과 조성물의 제조방법 |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0037043B1 (OSRAM) |
| JP (1) | JPS56150012A (OSRAM) |
| KR (1) | KR830004856A (OSRAM) |
| AU (1) | AU542560B2 (OSRAM) |
| CA (1) | CA1168154A (OSRAM) |
| CS (1) | CS261206B2 (OSRAM) |
| CY (1) | CY1361A (OSRAM) |
| DD (1) | DD157535A5 (OSRAM) |
| DE (1) | DE3167270D1 (OSRAM) |
| DK (1) | DK159414C (OSRAM) |
| EG (1) | EG15051A (OSRAM) |
| FI (1) | FI75991C (OSRAM) |
| GB (1) | GB2072015B (OSRAM) |
| GR (1) | GR73038B (OSRAM) |
| HK (1) | HK52787A (OSRAM) |
| HU (1) | HU185630B (OSRAM) |
| IE (1) | IE51035B1 (OSRAM) |
| IL (1) | IL62447A (OSRAM) |
| IN (1) | IN153498B (OSRAM) |
| IT (1) | IT8148073A0 (OSRAM) |
| MC (1) | MC1379A1 (OSRAM) |
| MY (1) | MY8700517A (OSRAM) |
| NO (1) | NO155377C (OSRAM) |
| NZ (1) | NZ196571A (OSRAM) |
| PH (1) | PH17800A (OSRAM) |
| PL (1) | PL138377B1 (OSRAM) |
| PT (1) | PT72703B (OSRAM) |
| SG (1) | SG20787G (OSRAM) |
| ZA (1) | ZA811896B (OSRAM) |
| ZW (1) | ZW6481A1 (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62277323A (ja) * | 1986-02-19 | 1987-12-02 | Sankyo Co Ltd | フマル酸ケトチフエン含有点眼液の製法 |
| IL80298A (en) * | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
| FR2622112A1 (fr) * | 1987-10-27 | 1989-04-28 | Medipro | Medicament comprenant l'association de polymyxine b, de neomycine et d'amphotericine b administre par vaporisation |
| ES2012532A6 (es) * | 1988-07-15 | 1990-04-01 | Cusi Lab | Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica. |
| AU655919B2 (en) * | 1990-02-22 | 1995-01-19 | Macnaught Pty Limited | Artificial tears |
| DE4229494A1 (de) * | 1992-09-04 | 1994-03-10 | Basotherm Gmbh | Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks |
| ES2079994B1 (es) * | 1992-10-07 | 1996-08-01 | Cusi Lab | Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica. |
| AU2004290862B2 (en) | 2003-11-20 | 2010-06-03 | Novo Nordisk A/S | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
| EA019867B1 (ru) * | 2007-10-08 | 2014-06-30 | Фовея Фармасьютикалс | Водные офтальмологические препараты |
| RS65380B1 (sr) | 2017-08-24 | 2024-04-30 | Novo Nordisk As | Glp-1 kompozicije i njihova upotreba |
| IL294520A (en) | 2020-02-18 | 2022-09-01 | Novo Nordisk As | Pharmaceutical formulations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2703777A (en) * | 1950-05-02 | 1955-03-08 | Iso Sol Company Inc | Ophthalmological preparations and vehicles and method of making the same |
| GB1340517A (en) * | 1969-12-01 | 1973-12-12 | Burton Parsons Chemicals Inc | Ophthalmic solution |
| US3898330A (en) * | 1973-08-01 | 1975-08-05 | Squibb & Sons Inc | Corticosteroid phosphate salts/neomycin sulfate ophthalmic |
| NL7416636A (nl) * | 1973-12-27 | 1975-07-01 | Wellcome Found | Farmaceutisch preparaat. |
-
1981
- 1981-03-20 DE DE8181102132T patent/DE3167270D1/de not_active Expired
- 1981-03-20 GR GR64460A patent/GR73038B/el unknown
- 1981-03-20 IE IE617/81A patent/IE51035B1/en not_active IP Right Cessation
- 1981-03-20 AU AU68567/81A patent/AU542560B2/en not_active Expired
- 1981-03-20 NZ NZ196571A patent/NZ196571A/xx unknown
- 1981-03-20 ZA ZA00811896A patent/ZA811896B/xx unknown
- 1981-03-20 FI FI810870A patent/FI75991C/fi not_active IP Right Cessation
- 1981-03-20 DD DD81228491A patent/DD157535A5/de not_active IP Right Cessation
- 1981-03-20 IL IL62447A patent/IL62447A/xx not_active IP Right Cessation
- 1981-03-20 ZW ZW64/81A patent/ZW6481A1/xx unknown
- 1981-03-20 DK DK127181A patent/DK159414C/da not_active IP Right Cessation
- 1981-03-20 PH PH25391A patent/PH17800A/en unknown
- 1981-03-20 IT IT8148073A patent/IT8148073A0/it unknown
- 1981-03-20 CY CY136181A patent/CY1361A/xx unknown
- 1981-03-20 KR KR1019810000921A patent/KR830004856A/ko not_active Ceased
- 1981-03-20 JP JP4662981A patent/JPS56150012A/ja active Granted
- 1981-03-20 HU HU81723A patent/HU185630B/hu unknown
- 1981-03-20 MC MC811508A patent/MC1379A1/xx unknown
- 1981-03-20 CS CS812056A patent/CS261206B2/cs unknown
- 1981-03-20 PL PL1981230236A patent/PL138377B1/pl unknown
- 1981-03-20 GB GB8108806A patent/GB2072015B/en not_active Expired
- 1981-03-20 PT PT72703A patent/PT72703B/pt unknown
- 1981-03-20 NO NO810961A patent/NO155377C/no not_active IP Right Cessation
- 1981-03-20 CA CA000373477A patent/CA1168154A/en not_active Expired
- 1981-03-20 EP EP81102132A patent/EP0037043B1/en not_active Expired
- 1981-03-21 EG EG155/81A patent/EG15051A/xx active
- 1981-03-21 IN IN306/CAL/81A patent/IN153498B/en unknown
-
1987
- 1987-02-26 SG SG207/87A patent/SG20787G/en unknown
- 1987-07-09 HK HK527/87A patent/HK52787A/en not_active IP Right Cessation
- 1987-12-30 MY MY517/87A patent/MY8700517A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR830004856A (ko) | 안정화된 안과 조성물의 제조방법 | |
| KR840004040A (ko) | 수경성 시멘트 조성물 | |
| DE3477879D1 (en) | Soft gelatin capsules containing polyethylene glycol and process for preparing them | |
| ES477351A1 (es) | Procedimiento de conservacion de composicion a base de dis- persiones acuosas de esferillas llamadas liposomas. | |
| DE2967237D1 (en) | Liquid detergent composition containing ternary surfactant system | |
| KR840002650A (ko) | 유비데카레논을 함유하는 약학적 조성물 | |
| ES2053615T3 (es) | Procedimiento mejorado para la preparacion de di-metil-eter puro. | |
| ES8201419A1 (es) | Un metodo para preparar una solucion acuosa de nitrogliceri-na | |
| KR900700048A (ko) | 경질 표면을 세척하거나 유지하기 위한 1회용 함침 와이프(wipe) | |
| SE7710840L (sv) | Enzymstabilisering | |
| KR830009714A (ko) | 디알데히드 함유 조성물 | |
| KR900700922A (ko) | 수성 현상용액 및 포지티브-작용성 감광성 내식막 조성물 현상에 있어서의 이의 용도 | |
| FI824254A0 (fi) | Foerfarande foer foerbaettring av fyllningskapaciteten av tobak, speciellt skuren tobak | |
| KR840007730A (ko) | 고결정성 나트륨 세포페라존의 제조방법 | |
| SE7611891L (sv) | Herbicid | |
| KR860002274A (ko) | 저장성 카모밀레 추출물의 제조방법 | |
| KR840004120A (ko) | 아즈렌 유도체의 안정화 아즈렌 유도체의 안정화방법 | |
| KR930700397A (ko) | 레졸신올 제조방법 | |
| KR840000901A (ko) | 옥센돌론 수성 현탁제의 제조방법 | |
| KR840005456A (ko) | 결정성 나트륨 세포페라존의 제조방법 | |
| KR850002955A (ko) | 맨솔이 함유된 고압산소의 제조방법 | |
| JPS5664789A (en) | Dried immobilized enzyme membrane and its preparation | |
| KR880000535A (ko) | 기화성 싸인펜의 제조방법(백색) | |
| JPS538371A (en) | Preserving method for selectively permeable membrane | |
| KR910010594A (ko) | 음극선관의 재생방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19810320 |
|
| PG1501 | Laying open of application | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19840428 Patent event code: PE09021S01D |
|
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19840905 Patent event code: PE09021S01D |
|
| PE0601 | Decision on rejection of patent |
Patent event date: 19850114 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19840905 Comment text: Notification of reason for refusal Patent event code: PE06011S01I Patent event date: 19840428 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |